Kidney cancer, also known as renal cancer, is a cancer of the renal cells or cells that line the tubules in the kidneys. According to the Centers for Disease Control and Prevention (CDC), the number of individuals diagnosed with kidney cancer has increased since the mid-1990s. While the risk factors for developing kidney cancer are largely unknown,
There are some preventive measures that may help reduce the risk of developing this type of cancer.
Healthy weight manegement
First and foremost, individuals should maintain a healthy weight. Research has shown that individuals who are obese or overweight have an increased risk of developing kidney cancer. However, not all obesity-related kidney cancers are preventable, as obesity is associated with other conditions that increase the risk of developing kidney cancer. Therefore, individuals should seek to maintain a healthy weight by engaging in regular physical activity, eating a balanced diet, and avoiding unhealthy weight-loss practices, such as fad diets.
Another important preventive measure is to avoid smoking. Smoking has been linked to a higher risk of developing both kidney and bladder cancer. In fact, the American Cancer Society states that smokers are two to three times more likely to develop kidney cancer than non-smokers. Therefore, individuals should avoid smoking and, if they currently smoke, quit smoking as soon as possible.
Keep your health complications in family history in mind
In addition to maintaining a healthy weight and avoiding smoking, individuals should also be mindful of their family history. According to the American Cancer Society, individuals with a close family member (e.g., parent, sibling, or child) with renal cell cancer have twice the risk of developing kidney cancer. Therefore, individuals should talk to their doctor about the potential risks associated with their family history.
Regular health-based screenings are mandatory
Finally, individuals should seek regular health screenings. If kidney cancer is detected early, it can often be treated more effectively. While screening for kidney cancer is not yet widely available, individuals should discuss the possibility of screening with their doctor based on their risk factors and health history.
Overall, there is no surefire way to prevent kidney cancer. However, individuals can take preventive measures to reduce their risk of developing this cancer, such as maintaining a healthy weight, avoiding smoking, being aware of their family history, and seeking regular health screenings. By taking these preventive measures, individuals can potentially reduce the risk of developing kidney cancer and maintain their health and well-being.
Medicine for kidney cancer
Pazopanib 200mg is a medication used in the treatment of cancer. It belongs to a group of drugs known as tyrosine kinase inhibitors, which prevent cell growth and division. Pazopanib works by targeting proteins located in the cells of a particular type of cancer and blocking their action.
Pazopanib treatment for two types of kidney cancer
Pazopanib is used to treat two types of cancer: renal cell carcinoma (RCC) and soft tissue sarcoma (STS). When used to treat RCC, pazopanib is usually prescribed after other treatments, such as immunotherapy and targeted therapy, have been unsuccessful. STS, is generally given when other chemotherapy treatments have failed.
Mode of administration of pazopanib
Pazopanib comes in tablet form and is typically taken once a day. Patients should take the medication at about the same time each day and can take it with or without food. To get the most benefit from the medication, it is important to take it consistently. If a dose is missed, the patient should contact their doctor for instructions.
Side effects of pazopanib
Like all medications, pazopanib comes with the potential for side effects. These can vary in intensity from mild to severe and may include nausea, fatigue, vomiting, loss of appetite, diarrhea, headache, constipation, dizziness, and rash. Some less common side effects can include hair loss, high blood pressure, and liver or kidney problems. It is important to tell the doctor immediately if any of these side effects occur so they can be managed.
Pazopanib can also interact with other medications a person may be taking. It is essential to provide the doctor with a detailed list of all current medications, supplements, and herbal remedies that are being taken to avoid any interactions.
Overall, pazopanib is an effective medication for the treatment of RCC and STS. It is important for patients to take the medication as prescribed and to notify the doctor of any changes in symptoms or side effects. pazopanib 200mg tablet can be an important part of a comprehensive treatment plan for cancer patients.
Other medicines for kidney cancer
Renal cell carcinoma (RCC) is a type of cancer that originates in the cells of the kidney. It is the most common form of kidney cancer, accounting for up to 85% of all diagnoses. While there is no guaranteed cure for RCC, numerous treatment options exist to help manage the symptoms and prolong a patient’s life. In addition to traditional treatments such as surgery and chemotherapy, a variety of other medicines are available to provide relief to patients living with kidney cancer.
Targeted therapies for kidney cancer
In recent years, research has steadily increased on the effectiveness of targeted therapies, which are designed to block the growth and spread of cancer cells. An example of this is sunitinib, which interferes with the pathways used by RCC cells to grow, divide, and spread. Other targeted drugs include everolimus, axitinib, pazopanib, tivozanib, and cabozantinib. In some cases, these drugs may be recommended before or after surgery.
Effective action of immunotherapy drugs
Immunotherapy drugs, such as nivolumab and ipilimumab, are also available to provide relief to patients with RCC. These drugs work by boosting the patient’s own immune system in order to fight cancer. Immunotherapy is typically used in patients whose tumors have become resistant to targeted therapies. While these drugs are generally well-tolerated, side effects are common and can include fatigue, rash, and decreased appetite.
In addition to the aforementioned treatments, a variety of other medicines have been shown to be effective in managing RCC. One option is everolimus, which is used to inhibit tumors’ blood vessels which, in turn, suppresses their growth. Additionally, temsirolimus is a medicine that interferes with the levels of proteins that influence cancer cell growth and division. And finally, bevacizumab helps prevent new blood vessels from forming and is useful for slowing down the progression of RCC.